The Hematologist COVID-19 Resources
The Hematologist is dedicated to covering important topics at the intersection of hematology and COVID-19 treatment. Please browse the available articles and podcasts below.
COVID-19 Articles from The Hematologist
Please find the latest COVID-19 research articles published in The Hematologist. All articles in this collection are freely available to read.
Hematologic Therapies Being Studied for Coronavirus: Capitalizing on Progress
Unmasking the Immunopathological Characteristics of COVID-19: Monocytes Grow With the Flow and Lymphocytes Shelter in Place?
ASH Members Respond to COVID-19 Challenges
President's Column: The New Normal
Image Challenge: Spots and Dots
#ASH20: An Unconventionally Conventional Meeting
2020 ASH News Daily Editor Dr. Ahmar Zaidi provides a wrap-up of the 2020 ASH Annual Meeting.
Are Patients With Blood Cancers at a Higher Risk of COVID-19 Infection?
ASH Advocates Take Part in the First Virtual Hill Days for Hematology
Read about ASH advocates’ experience with the first ever virtual Hill Days.
ASH Celebrates Advocacy Victories and Looks Toward the Future
Read about ASH’s advocacy successes in the past and planned initiatives for the future.
Being ASH President During a Pandemic
ASH President Dr. Stephanie Lee reflects on her ASH presidency during a tumultuous year.
Climbing Out of the Valley
Editor-in-Chief Dr. Laura Michaelis shares her thoughts on issues raised in the field of hematology over the past 18 months.
Complement and Thrombosis: What Is, and What Might Be
Dr. Eric Tseng discusses a broader understanding of how the complement and coagulation systems are intertwined.
Convalescent Plasma for COVID-19: An Old Therapy for a Novel Pathogen
Getting Answers Rapidly in the Time of COVID-19: The RAPID COVID COAG Trial
Dr. Eric Tseng provides commentary on RAPID COVID COAG, testing therapeutic anticoagulation versus standard of care .
How COVID-19 Has Changed ASH Advocacy
In Anticipation of the Wave
President's Column: Masking, Vaccination, and Research Needed to Protect Our Most Vulnerable Against COVID-19
ASH President-Elect Dr. Jane Winter and ASH President Dr. Martin Tallman discuss the protection of immune-compromised patients.
My Poor Self-Care During the Pandemic
In his inaugural President’s Column, 2021 ASH President Dr. Martin S. Tallman ushers in a new year for ASH.
Practical Issues in Lymphoma Care During the COVID-19 Pandemic
Drs. Lisa Hicks and Abi Vijenthira discuss the impact of COVID-19 on lymphoma care.
COVID-19: ASH’s Response Draws on the Strength of Our Community
Rethinking Our Work
Rethinking Professional Meetings for the Virtual Era
Editor-in-Chief Dr. Laura Michaelis discusses virtual scientific meetings and looks forward to the 2020 ASH Annual Meeting.
The Challenge We Face: Sickle Cell Disease and the COVID-19 Pandemic
The COVID Coagulopathy Conundrum: Facts, Fiction, and Fantasy
Things Done Right in 2020
Editor-in-Chief Dr. Laura Michaelis discusses successes of ASH and the hematology community amidst COVID-19.
What Is the Price of Preventing COVID-19 Infection? Rare Thrombotic/Thrombocytopenic Events Reported After Vaccination
Drs. Damon Houghton and Anand Padmanabhan shed light on rare thrombotic events reported in patients after COVID-19 vaccination.